Product
Supplier
Encyclopedia
Inquiry
Home > News > Pharma News > Huawei Layout Medical Circle: 5G, Medical Equipment, Preemption of Hospital

Huawei Layout Medical Circle: 5G, Medical Equipment, Preemption of Hospital

ECHEMI 2019-05-31

Huawei-Layout-Medical-Circle-5G,-Medical-Equipment,-Preemption-of-Hospital

The popularization and spread of 5G technology will bring great changes to existing medical devices and hospitals.

Recently, Huawei has been at the forefront of public opinion, from the United States issued a 90-day delayed ban on Huawei, to Huawei publicly stated that "no need for American chips, Huawei is OK", and then a letter to employees was screened by friends.

May 21, Huawei founder and concurrent CEO. Zhengfei, interviewed by several media in Shenzhen headquarters, answered many questions from the outside world, revealed his views on the US crackdown on Huawei and how Huawei would respond. In response to a question from Xinhua News Agency reporters, said: "Some of our marginal low-end products are not ready for war, because it will be eliminated sooner or later, but will never be affected on 5G. 5G is not an atomic bomb. It benefits human society and can affect many fields.

As far as devices are concerned, 5G technology will accelerate the trend of miniaturization and intelligentization of medical devices, such as remote ultrasound and vehicle-borne CT. At the same time, 5G can better support continuous monitoring and sensory processing devices. Its large capacity can enable medical IUU to continuously collect real-time data of patients, so that more information will be recorded and monitored. More importantly, they will record and analyze people's health more comprehensively and continuously, and recommend appropriate treatment. It can also help telemedicine and alleviate the problem of uneven distribution of medical resources and cross-regional visits.

According to the report of arterial network, in the construction case of Zheng Dafu First Hospital, Huawei Wireless XLabs director once said that Huawei cooperated with operators to provide 5G solutions for customers. It is reported that the first remote 5G animal surgery and human surgery were completed by Huawei in cooperation with Unicom and Mobile respectively. At the same time, Huawei has made progress in many directions in the exploration of Xlabs in the wireless application scenario laboratory, including more than 280 partners in the industrial chain such as operators, hospitals and medical equipment providers, and has formed more than 40 cooperative research projects.

West China Hospital have jointly built a large data integration and application platform, and together with customers, planned and designed the top-level design and implementation of digital hospital in the new hospital area of West China Second Hospital; constructed security support system with colleague hospitals; and used micro-module solutions to help hospitals such as PLA General Hospital and Nanjing Drum Tower to build highly integrated and easy-to-maintain data. Heart. In March of this year, Huawei Terminal Co., Ltd. changed its business scope and added new medical devices (the second kind of medical devices), which attracted wide attention of the industry. Huawei responded by simply making smart wearable devices to connect to medical devices; on this basis, it may work with partners to provide health care assistance solutions in the future. The TruSeen 3.0 heart rate monitoring system independently developed by Huawei is a step forward in wearable devices. At the launch, Huawei joined with other third-class hospitals, including 301 hospitals, to develop arrhythmia detection algorithm to reduce the probability of adverse events such as stroke. At the same time, Huawei and 301 hospitals jointly carried out a heart health research project. In this project, Huawei also opens the closed-loop service and provides medical recommendation.

Huawei's focus in medical field is cloud computing. Huawei Cloud has been on line since July 2017. Up to now, Huawei Cloud has been able to provide five products: medical image diagnosis solution, biomedical solution, chronic disease care solution and telemedicine solution. Currently, the specific research and development achievements of Huaweiyun in the medical field include DLI gene sequencing scheme, AI analysis solution for pathological section of cloud cervical cancer and other AI products. Judging from the existing cases of Huawei Cloud, Huawei Cloud cooperates with Huada Zhisheng to rapidly realize the transmission of massive data and the expansion and sharing of computing power by using cloud computing. At present, half of the data of Huawei Zhisheng Genebank is running in the cloud. On image, Huawei and Yitu Medical Co-released Intelligent Medical Cloud on March 21.

Zhang Shaowei, Director of Huawei Cloud Medical and Health, once said, "Huawei Cloud, grasping the essence, aims to provide stable, reliable, secure and sustainable evolution of cloud services to meet the rapidly changing customer needs." It is interesting to note that in the past, people often referred to Myry as Huawei in the field of medical devices, but now Huawei has built a high wall and accumulated a large amount of food in the field of medical devices.

Disclaimer: ECHEMI reserves the right of final explanation and revision for all the information.

Looking for chemical products? Let suppliers reach out to you!

Comment
Comment
  • Life Sciences Industry Overview

    The coverage spans the global life sciences industry across pharmaceuticals and food & nutrition, tracking the shift from lowest-cost sourcing to supply continuity, quality, and risk management, along with product trends and the growing edge of differentiated, globally capable players.
    Published in: June.2026

Trade Alert

Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)

Scan the QR Code to Share

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.